Brief: Nanexa Posts Positive Results From Preclinical Study Of NEX-22

Nanexa AB

22/08/2023 14:03

Aug 22 (Reuters) - Nanexa AB  NANEXA.ST :
    * NANEXA CONFIRMS CONTINUED POSITIVE RESULTS FROM A NEW
PRECLINICAL STUDY OF NEX-22
    * DATA SHOW RELEASE PROFILE OF NEX-22 CAN BE OBTAINED FOR AT
LEAST
28 DAYS, WHICH WAS DURATION OF PHARMACOKINETIC STUDY AND GOAL OF
STUDY

Source text for Eikon:  ID:nMFN1X6c3W 
Further company coverage:  NANEXA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))